Bristol Myers Squibb (BMY)

Short-Term Debt

$1.03B

Quarterly · Period ending: · USD

BMY logo

BMY Short-Term Debt

Latest reported$1.03B
BMY Quarterly Short-Term Debt ($415.00M → $1.03B)
High-resolution chart · PNG

BMY short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
1,027,000,000
2,506,000,000
2,463,000,000
4,723,000,000
4,909,000,000
3,726,000,000
2,227,000,000
1,243,000,000
3,708,000,000
6,359,000,000
3,281,000,000
5,617,000,000
3,188,000,000
2,923,000,000
4,400,000,000
2,299,000,000
5,120,000,000
7,693,000,000
5,117,000,000
5,238,000,000
2,828,000,000
1,937,000,000
2,504,000,000
3,721,000,000
4,954,000,000
3,998,000,000
3,479,000,000
635,000,000
612,000,000
421,000,000
1,703,000,000
1,620,000,000
1,716,000,000
1,925,000,000
987,000,000
1,461,000,000
1,306,000,000
1,197,000,000
992,000,000
990,000,000
155,000,000
106,000,000
139,000,000
642,000,000
755,000,000
330,000,000
590,000,000
401,000,000
365,000,000
281,000,000
359,000,000
680,000,000
764,000,000
1,372,000,000
826,000,000
751,000,000
236,000,000
145,000,000
115,000,000
182,000,000
187,000,000
135,000,000
117,000,000
243,000,000
290,000,000
208,000,000
231,000,000
286,000,000
124,000,000
156,000,000
154,000,000
135,000,000
1,799,000,000
1,781,000,000
1,891,000,000
1,879,000,000
256,000,000
241,000,000
187,000,000
630,000,000
189,000,000
234,000,000
231,000,000
277,000,000
292,000,000
244,000,000
1,883,000,000
1,650,000,000
1,009,000,000
776,000,000
232,000,000
1,288,000,000
1,902,000,000
2,247,000,000
1,379,000,000
799,000,000
785,000,000
308,000,000
174,000,000
1,734,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.